$KDP

Here’s What KDP’s Q2 Earnings Reveal About the Coffee Business Nobody’s Watching

Keurig Dr Pepper (KDP) reported Q2 revenue up 75.57% YoY to $7.31B and adjusted EPS up 16.33% to $0.57, boosted by JDE Peet’s consolidation. U.S. Refreshment Beverages net sales rose 10%, while U.S. Coffee net sales fell 3.2% and operating income dropped 24.7% due to green coffee inflation and tariffs. KDP reaffirmed low-double-digit adjusted EPS growth and net sales guidance of $25.9B to $26.4B.

Original reporting
Published Aug 8, 2026, 11:05 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 2:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Here’s What KDP’s Q2 Earnings Reveal About the Coffee Business Nobody’s Watching — source image
Decision brief

The 30-second read

$KDPNeutralMed
01

Why it matters

Consolidated revenue and adjusted EPS rose, but segment operating income for U.S. Coffee fell sharply. Management reaffirmed low-double-digit adjusted EPS growth and guided that Q2 likely represents the peak quarterly earnings contribution from JDE Peet’s in 2026 as timing benefits fade.

02

Market read

Traders get a quarter-specific earnings bridge (adjusted EPS up, GAAP EPS down) plus a forward-looking CFO ceiling on JDE Peet’s contribution, which can reprice expectations for the back half of 2026.

03

What to watch

GAAP EPS is distorted by purchase-price-allocation depreciation from the acquisition; traders may want to focus on adjusted EPS trajectory and the stated 2026 high watermark for JDE Peet’s contribution when modeling subsequent quarters.

Relevance 8/10Novelty 7/10Timing: post-Q2 earnings, ahead of the back-half cost and tariff normalization narrative

Background

The piece frames KDP’s Q2 as the first fully consolidated period with JDE Peet’s, then contrasts beverage strength with coffee margin pressure.

Company-level read

Ticker impact

$KDPNeutralMedium confidence
Context

Keurig Dr Pepper reported Q2 revenue up 75.57% YoY to $7.31B on JDE Peet’s consolidation, while U.S. Coffee sales fell 3.2% and operating income dropped 24.7%.

Expected impact

Near-term trading likely hinges on whether investors focus on adjusted EPS strength and reaffirmed outlook versus the deterioration in U.S. Coffee operating income and GAAP EPS hit from purchase accounting.

Evidence & confidence

The article provides concrete segment deltas (U.S. Coffee net sales -3.2%, segment operating income -24.7%) plus a CFO comment that Q2 is the 2026 high watermark for JDE Peet’s contribution, which can shift expectations for subsequent quarters even as full-year adjusted EPS guidance is reaffirmed.

Market effects

Highlights ongoing cost and tariff pass-through risk for packaged coffee, while showing resilience in refreshment beverages and energy brands.

Primarily U.S.-driven segment pressure (U.S. Coffee) versus U.S. Refreshment Beverages strength.

Limited direct global read-through beyond the acquisition-driven consolidation effects from JDE Peet’s.

Counterpoint

Investors may be over-weighting coffee weakness; the article suggests the cost envelope should ease in the back half as lower-cost inventory and softer tariff impacts reach the P&L.

Key entities

  • Keurig Dr Pepper

    Subject of the article, reporting Q2 results, segment performance, and reaffirmed full-year guidance amid JDE Peet’s consolidation.

  • JDE Peet’s

    Acquired business whose consolidation drove revenue and operating income, with CFO commentary on 2026 contribution peaking in Q2.

  • Anthony DiSilvestro

    KDP CFO quoted on the expected peak contribution from JDE Peet’s in 2026 and shifting economics back to U.S. Coffee.

Related articles

$KDPMed

Keurig Dr Pepper Inc. Q2 2026 Earnings Call Summary

Keurig Dr Pepper reported Q2 2026 results that exceeded expectations, citing double-digit U.S. Refreshment Beverages growth and day-one integration of JDE Peet's. Dr Pepper Zero Sugar grew 30% in retail sales and energy reached 9% market share. U.S. Coffee faced margin pressure from hedging and tariffs. KDP reaffirmed low double-digit EPS growth for 2026 and low-double-digit legacy growth at the high end of 4% to 6%.

$KDPMedAI 8/10

Keurig Dr Pepper Reaffirms Forecast On Strong Soda, Energy Drink Demand

Keurig Dr Pepper (KDP) kept its annual forecast after Q2 results beat analysts, supported by stronger soda and energy drink demand while its coffee business weakened. US Refreshment Beverages sales rose 10%, with gains in Dr Pepper Zero Sugar, Ghost and Electrolit. Net sales were $7.31B, up 75.6%, and adjusted EPS was 57 cents. 2026 guidance: $25.9B-$26.4B net sales and low double-digit EPS growth.

$KDPMedAI 8/10

Why Is Keurig Dr Pepper Stock Gaining Thursday? - Keurig Dr Pepper (NASDAQ:KDP)

Keurig Dr Pepper (NASDAQ:KDP) reported adjusted EPS of 57 cents, above the 54-cent consensus, and revenue of $7.31B vs $7.24B expected. GAAP net sales rose 75.6% year over year, largely from the JDE Peet’s acquisition. Segment results showed U.S. Refreshment up, U.S. Coffee down. Free cash flow was $714M. KDP reaffirmed 2026 revenue guidance of $25.9B to $26.4B.

$KDPMed

Keurig Dr Pepper maintains annual forecasts after quarterly results beat

Keurig Dr Pepper kept its annual forecasts after Q2 results beat expectations. According to LSEG, net sales rose 75.6% to $7.31B vs $7.24B expected, and adjusted profit was 57 cents per share vs 54 cents expected. The U.S. Refreshment Beverages division sales rose 10%. For 2026, it expects net sales of $25.9B to $26.4B and low-double-digit adjusted EPS growth.

$KDPMed

Why is Keurig Dr Pepper stock climbing today?

Keurig Dr Pepper shares rose about 1% in pre-open after the company reported Q2 adjusted EPS of $0.57 vs $0.54 expected and net sales of $7.31B vs about $7.24–$7.26B. The beat was attributed to U.S. Refreshment Beverages growth and early benefits from its April 2026 $18B JDE Peet’s acquisition. FY2026 revenue guidance was kept at $25.90–$26.40B.